Von Willebrand Disease in Dogs

Von Willebrand disease (VWD), also known as bleeding disorder or canine hemorrhagic disorder, is a genetic condition. It affects blood clotting because of a deficiency or dysfunction of von Willebrand factor. VWD is relatively common in dogs, with prevalence varying depending on the breed and type. Severity ranges from mild to severe, influenced by the level of von Willebrand factor present and the specific type of the disease.

The primary cause of VWD is a genetic mutation. This mutation affects the production or function of von Willebrand factor, leading to abnormal blood clotting. Since it is hereditary, VWD is passed down through generations.

There are no secondary causes for VWD, as it is inherently a genetic condition. However, other factors, like stress and hormonal changes, can exacerbate bleeding tendencies in affected dogs. Certain medications may also worsen the condition.

Risk factors for VWD include breed predisposition and a family history of the disease. Dogs from breeds with a higher prevalence of VWD are more likely to inherit the condition, making genetic testing important for breeders.

• Doberman Pinschers
• German Shepherds
• Golden Retrievers
• Standard Poodles
• Shetland Sheepdogs
• Scottish Terriers
• Pembroke Welsh Corgis
• Miniature Schnauzers
• Basset Hounds
• Manchester Terriers

Primary symptoms of VWD include prolonged bleeding from cuts or injuries. Dogs may also experience excessive bleeding during surgery and spontaneous bleeding from the nose or gums. These symptoms occur because of the lack of von Willebrand factor.

Secondary symptoms may involve blood in the urine or stool, bruising, and anemia from chronic blood loss. These symptoms can indicate more serious underlying issues and should be addressed by a veterinarian promptly.

Other symptoms may include lameness or swelling in joints, caused by bleeding into joint spaces. These occurrences are less common but can cause significant discomfort and mobility issues for the affected dog.

Diagnosis of VWD typically involves blood tests. These tests measure the level of von Willebrand factor and assess the dog’s clotting ability. Also, genetic testing can identify specific mutations linked to the disease.

Veterinarians conduct a thorough clinical examination to confirm VWD. They look for clinical signs such as excessive bleeding and may use imaging tests if joint bleeding is suspected. Correct diagnosis is important for effective treatment.

VWD should be differentiated from hemophilia, immune-mediated thrombocytopenia, and liver disease. These conditions also affect clotting but require different treatments, making correct diagnosis essential.

Treatment for VWD may involve desmopressin administration. This medication can temporarily increase von Willebrand factor levels, helping to manage bleeding episodes. In severe cases, blood transfusions may be necessary.

Therapy and medication can help control symptoms and improve quality of life. It is important to follow veterinary guidelines and monitor the dog’s response to treatment. Surgical interventions are rare but may be required to manage complications.

Managing VWD involves avoiding situations that could lead to injury or bleeding. Regular monitoring of the dog’s condition is important, as is adjusting lifestyle or activity levels to reduce risks. A careful approach can prevent complications.

Medication and therapy play essential roles in managing VWD. Regular check-ups allow for timely changes to the treatment plan. Monitoring the dog’s health helps identify any changes in condition that require attention.

There is no known prevention for VWD. Responsible breeding practices can help reduce its incidence by avoiding the breeding of affected dogs. Genetic testing is an essential tool for breeders to prevent the spread of VWD.

Diet and lifestyle changes can support overall health, but will not prevent VWD. Early detection through regular veterinary visits can help manage the condition, ensuring a better quality of life for the dog.